Hanger acquired Liberating Technologies Inc (LTI), a research organization founded in 2000 previously owned by Coapt. Since 2008, LTI’s specialized research team has secured numerous government-funded grants to pursue cutting-edge, high-impact concepts, and develop next-generation O&P technologies.
“The addition of LTI strengthens Hanger’s continued commitment to expanding research and development, advancing clinical practice, and improving patient outcomes through evidence-based care,” said Hanger CEO Pete Stoy. “This partnership also reflects our ambition to accelerate global technological progress for O&P patients and to join forces with current and future collaborators to drive the next generation of innovation.”
The LTI team will continue leading its current grant-funded initiatives—including advancing voice recognition technology for improved prosthesis control, developing socket cooling systems to support residual limb skin health, and optimizing electrode configurations for pattern recognition control to help prosthesis users achieve optimal functional outcomes—while also actively pursuing new research and development opportunities to expand the impact of their work.
“We are excited about this opportunity to become a part of the Hanger ecosystem, which will provide LTI with the technical resources and the access to clinical insights and clinical data that can help us further drive and enhance innovation,” said Todd Farrell, PhD, vice president of research and development, Hanger.
Hanger acquired Coapt in 2025, and with this acquisition, the full Coapt portfolio is owned by Hanger.
